Publications by authors named "Charles Ballow"

Claim this Profile
E
Effects of a State- and Use-Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study.
Regan Fong, Charles H Ballow, Himanshu Naik, Deb Steiner, Joanne Palmer

J Clin Pharmacol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlation.
John P Sabo, Jens Kort, Charles Ballow, Angela D M Kashuba, Manuel Haschke

J Clin Pharmacol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovir.
John P Sabo, Jens Kort, Charles Ballow, Manuel Haschke, Manuel Battegay

Clin Infect Dis· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A.
Charles Ballow, Anissa Leh, Kimberly Slentz-Kesler, Jim Yan, David Haughey

J Clin Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.
William E Pelham, James G Waxmonsky, Jerome Schentag, Charles H Ballow, Carlos J Panahon

J Atten Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects.
Shekman L Wong, Michael R Goldberg, Charles H Ballow, Michael M Kitt, Steven L Barriere

Pharmacotherapy· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of BILR 355 after multiple oral doses coadministered with a low dose of ritonavir.
Fenglei Huang, Kristin Drda, Thomas R MacGregor, Joseph Scherer, Lois Rowland, Charles Ballow

Antimicrob Agents Chemother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers.
David E Martin, Robert Blum, John Wilton, Judy Doto, Hal Galbraith, Charles Ballow

Antimicrob Agents Chemother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers.
David E Martin, Robert Blum, Judy Doto, Hal Galbraith, Charles Ballow

Clin Pharmacokinet· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.
Mary B Wire, Charles H Ballow, Julie Borland, Mark J Shelton, Yu Lou

Antimicrob Agents Chemother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of GW433908 and ritonavir, with and without efavirenz, in healthy volunteers.
Mary Beth Wire, Charles Ballow, Sandra L Preston, Craig W Hendrix, Peter J Piliero

AIDS· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific.
Jan M Bell, John D Turnidge, Charles H Ballow, Ronald N Jones,

J Antimicrob Chemother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of food on the pharmacokinetics of (-) and (+) dOTC when administered as an oral racemate.
Patrick F Smith, Alan Forrest, John M Adams, Charles H Ballow

J Clin Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).
Charles H Ballow, Douglas J Biedenbach, Flavia Rossi, Ronald N Jones,

Braz J Infect Dis· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter evaluation of linezolid antimicrobial activity in North America.
Charles H Ballow, Ronald N Jones, Douglas J Biedenbach,

Diagn Microbiol Infect Dis· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Double-Blind, Randomized Comparison of Aztreonam Plus Clindamycin with Tobramycin Plus Clindamycin in Abdominal Infections.
Charles H. Ballow, Philip B. Wels, Lynda S. Welage, Paul Walczak, James S. Williams

Am J Ther· June 1995

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis